Artificial intelligence in prostate MRI: Comparative diagnostic performance in a high-prevalence cohort.

AI / informaticsActa radiologica (Stockholm, Sweden : 1987)· Jul 2026

Artificial intelligence in prostate MRI: Comparative diagnostic performance in a high-prevalence cohort.

Nádia Gonçalves Ferreira, Owen Matthew Truscott Thomas, Kjell-Inge Gjesdal … Jonn Terje Geitung

Read paper

PathologyAI / informaticsDiagnosisQ3IF 1.3

Artificial intelligence missed more clinically significant prostate cancers on MRI than radiologists

Artificial intelligence in prostate MRI: Comparative diagnostic performance in a high-prevalence cohort.

Nádia Gonçalves Ferreira … Jonn Terje Geitung

Acta radiologica (Stockholm, Sweden · Jul 2026 · Q3 in General Medicine

Background

Artificial intelligence (artificial intelligence) is increasingly used in prostate cancer diagnostic workflows but remains insufficiently validated in high-prevalence cohorts often encountered in academic referral centers.

Purpose

To compare the diagnostic performance of licensed artificial intelligence software with routine radiologist readings of prostate MRI, using histopathology as the reference standard.

Methods

Material and Methods In this retrospective study, 1000 patients underwent prostate MRI for suspected prostate cancer (between May 2020 and December 2024), followed by transperineal biopsy; 391 subsequently underwent radical prostatectomy.

n = 1000 patients

Results

Artificial intelligence was more likely than radiologists to miss serious prostate cancers on MRI

96%

Sensitivity

20.9%

Specificity

More results

Artificial intelligence assigned more cases to PI-RADS 1-2 and fewer to PI-RADS 3 (κ = 0.388; P <.001).

At the PI-RADS ≥3 threshold, radiologists showed sensitivity 96.0%, specificity 20.9%, accuracy 85.9%, positive predictive value 88.7%, and negative predictive value 45.0%, compared with 91.3%, 37.2%, 84.0%, 90.3%, and 40.0% for artificial intelligence ( P <.001).

More results

ConclusionAI showed diagnostic performance comparable to that of radiologists for csPCa detection, with no significant difference in AUC.

“

Conclusion

Artificial intelligence reduced indeterminate PI-RADS 3 scores but missed more significant cancers.

Artificial intelligence in prostate MRI: Comparative diagnostic performance in a high-prevalence cohort.

Artificial intelligence in prostate MRI: Comparative diagnostic performance in a high-prevalence cohort.

Related papers